Analystreport

Takeda Pharmaceutical Company Limited (NYSE: TAK) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK)